Instil Bio, Inc. Revenue Breakdown
No Revenue Breakdown for TIL on this site yet.
- 2021-12-31: Total revenue $0.00.
- 2020-12-31: Total revenue $138.00K.
Source checked: the stored Revenue Breakdown page for TIL.
Revenue by product
Each year (12 month)
| Fiscal year end | Total revenue |
|---|---|
| 2021-12-31 | $0.00 |
| 2020-12-31 | $138.00K |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2021-12-31 | Not split by product $0.00 | $0.00 |
| 2021-09-30 | Not split by product $0.00 | $0.00 |
| 2021-06-30 | Not split by product $0.00 | $0.00 |
| 2021-03-31 | Not split by product $0.00 | $0.00 |
| 2020-12-31 | Not split by product $0.00 | $0.00 |
| 2020-09-30 | Not split by product $52.00K 100.00% | $52.00K |
| 2020-06-30 | Not split by product $42.00K 100.00% | $42.00K |
| 2020-03-31 | Not split by product $44.00K 100.00% | $44.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |